About biologit
biologit is a company based in Dublin (Ireland) founded in 2021 by Bruno Ohana and Nicole Baker. biologit has raised $1.09 million across 1 funding round from investors including Enterprise Ireland and Ryan Group Holdings. biologit offers products and services including biologit MLM-AI, biologit Database, Pharmacovigilance Services, and Veterinary Pharmacovigilance. biologit operates in a competitive market with competitors including DrugCard, Beijing Dongxie Network, Sentrx, Advera Health and My Meds & Me, among others.
- Headquarter Dublin, Ireland
- Founders Bruno Ohana, Nicole Baker
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.09 M (USD)
in 1 rounds
-
Latest Funding Round
$1.09 M (USD), Seed
Apr 10, 2022
-
Investors
Enterprise Ireland
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of biologit
biologit offers a comprehensive portfolio of products and services, including biologit MLM-AI, biologit Database, Pharmacovigilance Services, and Veterinary Pharmacovigilance.
AI-powered tool for automated literature screening in safety surveillance.
Hosts global literature sources with automatic de-duplication features.
Expert services for regulatory compliance in pharmacovigilance monitoring.
Monitoring solutions for veterinary safety and regulatory requirements.
People of biologit
Unlock access to complete
Leadership Team
2 people
Software Development Team
2 people
Staff Team
1 people
PV Team
1 people
Co Team
1 people
Unlock access to complete
Funding Insights of biologit
biologit has successfully raised a total of $1.09M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.09 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in biologit
biologit has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland and Ryan Group Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ryan Group Holdings is engaged in startup investment and support.
|
Locked | Locked | Locked | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Locked | Locked | Locked |
Investor details for biologit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by biologit
Investment portfolio details for biologit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - biologit
Detailed financials for biologit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biologit Comparisons
Peer comparison for biologit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of biologit
biologit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DrugCard, Beijing Dongxie Network, Sentrx, Advera Health and My Meds & Me, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug pharmacovigilance solutions are provided for pharmaceutical industries.
|
|
| Locked | Locked | Locked |
AI-based pharmacovigilance platform is developed for report analysis and monitoring.
|
|
| Locked | Locked | Locked |
Specialized pharmacovigilance software and services are developed and provided.
|
|
| Locked | Locked | Locked |
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
|
|
| Locked | Locked | Locked |
Adverse events and product quality are captured for life sciences.
|
Detailed competitors of biologit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biologit
Complete news archive for biologit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about biologit
biologit was founded in 2021 and raised its 1st funding round 1 year after it was founded.
biologit is headquartered in Dublin, Ireland.
Nicole Baker is the current CEO of biologit. They have also founded this company.
biologit is a funded company, having raised a total of $1.09M across 1 funding round to date.
Biologit was founded in 2021 and is based in Dublin, Ireland. AI-based tools are developed for drug pharmacovigilance within the pharmaceutical sector. Information from scientific abstracts, journals, and literature is collected, monitored, researched, assessed, and evaluated using these AI-assisted solutions. Operations emphasize data handling and analysis to support pharmacovigilance activities across relevant geographies.
biologit's top competitors include Sentrx, My Meds & Me and DrugCard.
biologit offers biologit MLM-AI, biologit Database, Pharmacovigilance Services, and Veterinary Pharmacovigilance.
biologit has 2 investors. Key investors include Enterprise Ireland, and Ryan Group Holdings.